Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2024 Filed Jul 31, 2024 23:56 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantOrdinary Shares | 6,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000084 · wk-form4_1722470162.xml · nonDerivative · entry 2 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,842 F3 · shares: Restrictions on the award shall lapse 33% each year following the Grant Date. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 23:56 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantOrdinary Shares | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000084 · wk-form4_1722470162.xml · nonDerivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,516 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 196 shares acquired through dividend reinvestment and 299 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:40 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 492 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000082 · wk-form4_1721421644.xml · derivative · entry 2 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 492 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:40 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 492 | $62.76 | $30,877.92 |
DisclosureSEC source: 0001613103-24-000082 · wk-form4_1721421644.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 157 shares acquired through dividend reinvestment and 143 shares purchased pursuant to the Employee Stock Purchase Plan since the last report filed by the reporting person. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:53 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,594 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000067 · wk-form4_1718146397.xml · derivative · entry 6 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,594 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:53 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,519 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000067 · wk-form4_1718146397.xml · derivative · entry 5 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,594 Underlying: Ordinary Shares · 17,519 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:53 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
SaleOrdinary Shares | 1,594 | $83.82 | $133,609.08 |
DisclosureSEC source: 0001613103-24-000067 · wk-form4_1718146397.xml · nonDerivative · entry 4 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,348 Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:53 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
SaleOrdinary Shares | 17,519 | $83.76 | $1,467,391.44 |
DisclosureSEC source: 0001613103-24-000067 · wk-form4_1718146397.xml · nonDerivative · entry 3 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,942 Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:53 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionOrdinary Shares | 1,594 | $62.76 | $100,039.44 |
DisclosureSEC source: 0001613103-24-000067 · wk-form4_1718146397.xml · nonDerivative · entry 2 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:53 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionOrdinary Shares | 17,519 | $62.76 | $1,099,492.44 |
DisclosureSEC source: 0001613103-24-000067 · wk-form4_1718146397.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,204 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2024 Filed May 3, 2024 13:11 UTC |
OLEARY DENISE MDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000053 · wk-form4_1714756269.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,057 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:10 UTC |
Lofton Kevin EDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000051 · wk-form4_1714756207.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,230 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:08 UTC |
Fonseca LidiaDirector
|
Tax withholdingOrdinary Shares | 162 | $80.89 | $13,104.18 |
DisclosureSEC source: 0001613103-24-000048 · wk-form4_1714756117.xml · nonDerivative · entry 1 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,682 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:11 UTC |
Powell Kendall JDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000054 · wk-form4_1714756295.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,843 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:08 UTC |
DONNELLY SCOTT CDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000047 · wk-form4_1714756087.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,604 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:09 UTC |
HOGAN RANDALL JDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000050 · wk-form4_1714756178.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,088 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:07 UTC |
ARNOLD CRAIGDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000046 · wk-form4_1714756055.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,275 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:10 UTC |
NABEL ELIZABETH GDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000052 · wk-form4_1714756240.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,674 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:09 UTC |
Goldsmith Andrea JoDirector
|
Tax withholdingOrdinary Shares | 192 | $80.89 | $15,530.88 |
DisclosureSEC source: 0001613103-24-000049 · wk-form4_1714756146.xml · nonDerivative · entry 1 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,306 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2024 Filed May 1, 2024 17:15 UTC |
OLEARY DENISE MDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000035 · wk-form4_1714598147.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,249 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 1,246 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:14 UTC |
Lofton Kevin EDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000033 · wk-form4_1714598084.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,422 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 66 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:12 UTC |
Fonseca LidiaDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000029 · wk-form4_1714597965.xml · nonDerivative · entry 1 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,844 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 55 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:16 UTC |
Powell Kendall JDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000036 · wk-form4_1714598182.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,035 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 877 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:12 UTC |
DONNELLY SCOTT CDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000028 · wk-form4_1714597936.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,796 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 148 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:11 UTC |
ARNOLD CRAIGDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000027 · wk-form4_1714597905.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,467 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 66 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:13 UTC |
HOGAN RANDALL JDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000031 · wk-form4_1714598024.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,280 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 66 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:15 UTC |
NABEL ELIZABETH GDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000034 · wk-form4_1714598113.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,866 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 66 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:14 UTC |
Lewis Gregory PDirector
|
GrantOrdinary Shares | 1,821 | $80.86 | $147,246.06 |
DisclosureSEC source: 0001613103-24-000032 · wk-form4_1714598053.xml · nonDerivative · entry 1 Lewis Gregory P · CIK 0001748656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,821 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:13 UTC |
Goldsmith Andrea JoDirector
|
GrantOrdinary Shares | 2,165 | $80.86 | $175,061.90 |
DisclosureSEC source: 0001613103-24-000030 · wk-form4_1714597994.xml · nonDerivative · entry 1 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,498 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 66 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 08, 2024 Filed Apr 9, 2024 20:08 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
SaleOrdinary Shares | 854 | $83.14 | $71,001.56 |
DisclosureSEC source: 0001613103-24-000016 · wk-form4_1712693283.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,925 F1 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $83.14 to $83.145. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 19:18 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Tax withholdingOrdinary Shares | 563 | $83.60 | $47,066.80 |
DisclosureSEC source: 0001613103-24-000013 · wk-form4_1709839127.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,779 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 412 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,035 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · derivative · entry 9 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 16,035 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,066 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · derivative · entry 8 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,066 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,594 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · derivative · entry 7 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,066 Underlying: Ordinary Shares · 1,594 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
SaleOrdinary Shares | 16,035 | $85.12 | $1,364,899.20 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 6 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,289 F3 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
SaleOrdinary Shares | 13,066 | $85.15 | $1,112,569.90 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 5 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,324 F2 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
SaleOrdinary Shares | 1,594 | $85.06 | $135,585.64 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,390 Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 16,035 | $74.84 | $1,200,059.40 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 13,066 | $62.76 | $820,022.16 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 1,594 | $62.76 | $100,039.44 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 19:42 UTC |
Kirk Jennifer MChief Accounting Officer
|
Tax withholdingOrdinary Shares | 1,159 | $88.09 | $102,096.31 |
DisclosureSEC source: 0001613103-24-000003 · wk-form4_1706902921.xml · nonDerivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,208 F1 · shares: The reported transaction represents the withholding of 1,159 shares of stock issuable upon the vesting of 3,507 restricted stock units. F2 · balance_after: This balance increased by 174 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 16:41 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
SaleOrdinary Shares | 4,997 | $82.17 | $410,603.49 |
DisclosureSEC source: 0001613103-23-000166 · wk-form4_1703090489.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,910 F1 · shares: This transaction was made pursuant to Mr. Wall's existing Rule 10b5-1 plan. Read SEC document |
| December 11, 2023 Filed Dec 12, 2023 14:53 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 1,952 | $79.35 | $154,891.20 |
DisclosureSEC source: 0001613103-23-000161 · wk-form4_1702410790.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,201 F2 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F3 · balance_after: Includes 1,062 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 14:55 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
Tax withholdingOrdinary Shares | 369 | $79.27 | $29,250.63 |
DisclosureSEC source: 0001613103-23-000164 · wk-form4_1702410897.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,410 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2 · balance_after: Includes 814 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 19:54 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 435 | $79.27 | $34,482.45 |
DisclosureSEC source: 0001613103-23-000163 · wk-form4_1702410865.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,907 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 769 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 14:53 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 716 | $79.27 | $56,757.32 |
DisclosureSEC source: 0001613103-23-000161 · wk-form4_1702410790.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,091 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 19:54 UTC |
Salmon SeanEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 435 | $79.27 | $34,482.45 |
DisclosureSEC source: 0001613103-23-000162 · wk-form4_1702410832.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,103 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2 · balance_after: Includes 812 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| October 30, 2023 Filed Nov 1, 2023 20:31 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,695 | $0.00 Strike: $69.97 | $0.00 |
DisclosureSEC source: 0001613103-23-000140 · wk-form4_1698870705.xml · derivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,695 Underlying: Ordinary Shares · 1,695 shares Expires 2033-10-30 F1 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 19:21 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 10,000 | $83.84 | $838,400.00 |
DisclosureSEC source: 0001613103-23-000120 · wk-form4_1692991290.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,723 F1 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $83.84 to $83.85. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 21:16 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
SaleOrdinary Shares | 1,000 | $83.38 | $83,380.00 |
DisclosureSEC source: 0001613103-23-000113 · wk-form4_1692220574.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,573 F1 · shares: This transaction was made pursuant to Mr. Wall's existing Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.